Panitumumab
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Panitumumab
Jun 8, 2024, 18:36 |
Dialogues
ASCO24 Updates: Introduction to the PanaMa Trial and its Objectives
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Apr 16, 2024, 11:36 |
Insight
Piotr Wysocki: Rechallenge with anti-EGFR antibodies is a feasible and safe strategy in refractory metastatic colorectal cancer patients with RAS/BRAFwt ctDNA
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Feb 15, 2024, 11:05 |
Blog
Kohei Shitara: Happy to report ctDNA analysis of PARADIGM at Nature Medicine
Kohei Shitara, Medical oncologist at National Cancer Center Hospital East, Japan, shared a post on…
Jan 10, 2024, 18:21 |
Blog
Top Precision Oncology articles of 2023 by Vivek Subbiah
Vivek Subbiah shared on X/Twitter: "By popular demand delighted to share the 'Top Precision Oncology…
Jun 19, 2023, 19:57 |
Drugs
FOLFOXIRI only adds 1.6 months PFS but increases toxicity significantly - Enrique Soto
Interesting results FOLFOXIRI only adds 1.6 months PFS but increases toxicity significantly (7 toxic…
All:
5
Posts:
1 - 100
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Facebook
RSS Feed
Twitter
Linkedin
Youtube